Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 9.69% and Operating profit at 9.70% over the last 5 years
2
With a fall in Net Sales of -14.18%, the company declared Very Negative results in Mar 25
3
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.23%
0%
-9.23%
6 Months
-7.98%
0%
-7.98%
1 Year
-19.06%
0%
-19.06%
2 Years
-24.11%
0%
-24.11%
3 Years
-31.6%
0%
-31.6%
4 Years
-53.8%
0%
-53.8%
5 Years
-57.88%
0%
-57.88%
Shandong Pharmaceutical Glass Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.69%
EBIT Growth (5y)
9.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.58
Tax Ratio
14.28%
Dividend Payout Ratio
43.63%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.33%
ROE (avg)
11.15%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
1.74
EV to EBIT
13.76
EV to EBITDA
9.50
EV to Capital Employed
1.99
EV to Sales
2.51
PEG Ratio
NA
Dividend Yield
2.89%
ROCE (Latest)
14.48%
ROE (Latest)
10.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
1,116.80
1,301.40
-14.18%
Operating Profit (PBDIT) excl Other Income
255.40
374.30
-31.77%
Interest
0.00
0.00
Exceptional Items
2.30
6.60
-65.15%
Consolidate Net Profit
147.50
254.40
-42.02%
Operating Profit Margin (Excl OI)
140.50%
217.00%
-7.65%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is -14.18% vs 10.83% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is -42.02% vs 16.16% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
5,070.70
4,935.30
2.74%
Operating Profit (PBDIT) excl Other Income
1,413.80
1,170.60
20.78%
Interest
3.20
3.10
3.23%
Exceptional Items
19.40
10.00
94.00%
Consolidate Net Profit
943.00
775.80
21.55%
Operating Profit Margin (Excl OI)
202.90%
171.30%
3.16%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.74% vs 18.87% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 21.55% vs 25.47% in Dec 2023
About Shandong Pharmaceutical Glass Co., Ltd. 
Shandong Pharmaceutical Glass Co., Ltd.
Packaging
No Details Available.
Company Coordinates 
No Company Details Available






